Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn

Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn

Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn

Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn

Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)

Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.